Latest Hematology Stories

LAGUNA HILLS, Calif., May 22, 2013 /PRNewswire/ -- Advanced Prenatal Therapeutics (APT), a privately held company, is developing a medical device that will help alleviate the high blood pressure and other symptoms associated with preeclampsia. APT's targeted apheresis cartridge is expected to be the first medical device specifically designed to treat preeclampsia, a leading cause of maternal and fetal death. Every year, preeclampsia affects approximately 300,000 pregnant women in the...

May is National Stroke Awareness Month. Learn the symptoms and act quickly at first signs of stroke. Trenton, NJ (PRWEB) May 17, 2013 Seeking prompt emergency care at the first sign of stroke is more important than ever because new interventions can open clots and restore blood flow to the brain, often reducing or preventing permanent damage. A new generation of mechanical blood clot retrieval devices, some available in just the past year, is making emergency interventions more effective,...

The DrugRisk Center is the web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com. Chicago, IL (PRWEB) May 16, 2013 The birth control safety center at DrugRisk.com is announcing new information on the site for women who have taken the contraceptives Yaz or Yasmin. A recent court update shows the number of cases filed alleging blood clots has fallen, as Bayer continues to settle claims*. DrugRisk.com was created to...

SHANGHAI, May, 13, 2013 /PRNewswire/ -- A special youth focused "Touch Your Heart - Donate for Love" blood drive campaign was launched recently under the auspices of the Shanghai Committee of the Youth League, Touchmedia, the Shanghai Blood Center and the Shanghai IT Youth Talent Association. As a part of the "Shanghai IT Youth Caring Plan", the campaign aims to assist public spirited IT entrepreneurs wanting to help in this crisis to donate blood themselves and help them use their...

Penn State University A gene associated with both protection against bacterial infection and excessive blood clotting could offer new insights into treatment strategies for deep-vein thrombosis -- the formation of a harmful clot in a deep vein. The gene produces an enzyme that, if inhibited via a specific drug therapy, could offer hope to patients prone to deep-vein clots, such as those that sometimes form in the legs during lengthy airplane flights or during recuperation after major...

Use of SpHb® Noninvasive Hemoglobin Is Part of Leading Medical Teaching Facility's Standardization to Masimo SET® Pulse Oximetry BURSA, Turkey and IRVINE, Calif., May 8, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI) and Uludag University Hospital, one of the top educational healthcare facilities in all of Turkey, announce that Uludag has added Masimo SpHb(® )- a breakthrough technology that allows clinicians to noninvasively and continuously monitor hemoglobin blood levels. The use...

Research adds to the growing body of evidence of neutrophils' role in dangerous blood clots BOSTON, May 6, 2013 /PRNewswire-USNewswire/ -- It takes more than platelets, thrombin and fibrin to build a deep vein thrombosis (DVT). Increasingly, researchers are recognizing that neutrophils--cells better known for their role in immune defense--play an active role in DVT formation by releasing platelet-catching nets made of chromatin, a tightly-wound mix of DNA and associated proteins....

More than 1,000 NuvaRing Lawsuits Filed on Behalf of Alleged Victims of NuvaRing Side Effects, Including Heart Attacks, Blood Clots and Strokes, are Currently Pending in the Federal NuvaRing Litigation. Columbus, OH (PRWEB) May 02, 2013 Wright & Schulte LLC, an experienced medical device injury law firm representing numerous women in NuvaRing lawsuits, notes that the federal judge overseeing the federal NuvaRing Lawsuit litigation in U.S. District Court, Eastern District of Missouri...

BRAINTREE, Mass., May 1, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) today announced that it has completed its previously announced acquisition of the assets of Hemerus Medical, LLC ("Hemerus"), a Minnesota-based company that develops innovative technologies for the collection of whole blood and for the processing and storage of blood components. (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) Haemonetics recently learned that the U.S. FDA approved...

The Supermodel Joins Katharina Harf of Delete Blood Cancer and Founding Corporate Sponsor Coty Inc. to Raise Awareness for the Cause NEW YORK, May 1, 2013 /PRNewswire/ -- Today, internationally renowned supermodel Georgia May Jagger will join Delete Blood Cancer, part of the world's largest bone marrow donor center, and leading global beauty company Coty Inc. to light up the Empire State Building in red and white to help raise awareness for the fight against blood cancer. Jagger will...